Baxter Hlthcare Corp Company Profile

✉ Email this page to a colleague

BAXTER HLTHCARE CORP has sixty-six approved drugs.

There are fifteen US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.

There are eight patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and twenty-four supplementary protection certificates in fourteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	METHOCARBAMOL	methocarbamol	SOLUTION;IM-IV	215065-001	Jul 14, 2022		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Baxter Hlthcare Corp	FUROSEMIDE	furosemide	INJECTABLE;INJECTION	202747-001	Jan 27, 2014	AP	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Baxter Hlthcare Corp	MICAFUNGIN IN SODIUM CHLORIDE 0.9%	micafungin sodium	SOLUTION;INTRAVENOUS	216142-002	Sep 29, 2023		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Baxter Hlthcare Corp	NOURESS	cysteine hydrochloride	SOLUTION;INTRAVENOUS	212535-001	Dec 13, 2019		DISCN	Yes	No	10,905,714	⤷ Try a Trial	Y			⤷ Try a Trial
Baxter Hlthcare Corp	HALOPERIDOL	haloperidol lactate	INJECTABLE;INJECTION	076791-001	Aug 25, 2004		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-001	Feb 24, 1998	7,915,229	⤷ Try a Trial
Baxter Hlthcare Corp	DOXIL (LIPOSOMAL)	doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL;INJECTION	050718-002	Jun 13, 2000	5,213,804	⤷ Try a Trial
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-002	Feb 24, 1998	6,207,661	⤷ Try a Trial
Baxter Hlthcare Corp	DOXIL (LIPOSOMAL)	doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL;INJECTION	050718-001	Nov 17, 1995	5,213,804	⤷ Try a Trial
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-002	Feb 24, 1998	6,900,184	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Canada	3170514	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2021183752	⤷ Try a Trial
Japan	2023517926	⤷ Try a Trial
China	115243675	⤷ Try a Trial
Brazil	112022015170	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	2013C/060	Belgium	⤷ Try a Trial	PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1189916	CA 2011 00005	Denmark	⤷ Try a Trial	PRODUCT NAME: REGADENOSON OG SALTE DERAF
1304992	SPC/GB13/061	United Kingdom	⤷ Try a Trial	PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
2957286	6/2019	Austria	⤷ Try a Trial	PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721
1189916	2/2011	Austria	⤷ Try a Trial	PRODUCT NAME: REGADENOSON UND DESSEN SALZE; REGISTRATION NO/DATE: EU/1/10/643/001 20100906
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.